Figure 2.
Mean change (%) in TPV (A) and TZV (B) from baseline over 48 months. Open bars, placebo/dutasteride-treated subjects (P/D); solid bars, dutasteride/dutasteride-treated subjects (D/D). TPV, total prostate volume; TZV, transition zone volume. Adapted from Debruyne F et al20 with permission from European Association of Urology.
